Stephen-Haynes Jackie, Callaghan Rosie, Stephens Claire
Professor and Consultant Nurse in Tissue Viability, Worcestershire Health and Care NHS Trust and Birmingham City University.
Tissue Viability Nurse, Worcestershire Health and Care NHS Trust.
Br J Nurs. 2017 Mar 23;26(6):S36-S41. doi: 10.12968/bjon.2017.26.6.S36.
This article describes a single-centre, non-comparative evaluation set out to assess the clinical performance and patient acceptability of a new carboxymethyl cellulose (CMC) wound dressing. Twenty patients in a community setting, aged between 34-97 years, were recruited. The progression of various types of wounds with different levels of exudate was documented over 4 weeks. No adherence to the wound bed or painful removal was reported in 18 patients, and the peri-wound skin was the same or had improved in all patients. When compared with the previous CMC dressing used by the authors, the new CMC dressing reported a longer wear time. These findings show a positive clinical performance and suggest a potential financial advantage when using the new dressing.
本文描述了一项单中心、非对照评估，旨在评估一种新型羧甲基纤维素（CMC）伤口敷料的临床性能和患者接受度。招募了20名社区患者，年龄在34至97岁之间。记录了4周内不同渗出水平的各类伤口的进展情况。18名患者未报告敷料与伤口床粘连或去除时疼痛，所有患者伤口周围皮肤状况相同或有所改善。与作者之前使用的CMC敷料相比，新型CMC敷料的佩戴时间更长。这些结果显示出良好的临床性能，并表明使用新型敷料可能具有经济优势。
